Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: A meta-analysis

Journal of Infection

Volumn 64, Issue 6, 2012, Pages 580-588

  Chang, Kai ^a   Lu, Weiping ^a   Wang, Junji ^a   Zhang, Kejun ^a   Jia, Shuangrong ^a   Li, Fake ^a   Deng, Shaoli ^a   Chen, Ming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Meta analysis; Rifampicin resistance; Tuberculosis; Xpert MTB RIF assay

Indexed keywords

RIFAMPICIN;

ARTICLE; BACTERIUM CULTURE; DIAGNOSTIC ACCURACY; EXTRAPULMONARY TUBERCULOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; META ANALYSIS; MIXED INFECTION; MULTIDRUG RESISTANT TUBERCULOSIS; POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SMEAR; TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; RIFAMPIN; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84862777446     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.02.012     Document Type: Article

References (43)

1. World Health Organization Global tuberculosis control 2010 2010, Publication no. WHO/HTM/2010.7, WHO, Geneva, Switzerland.
2. World Health Organization Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report of surveillance and response 2009, Publication no. WHO/HTM/TB/2010.3, WHO, Geneva, Switzerland.
3. Wallis R.S., Pai M., Menzies D., Doherty T.M., Walzl G., Perkins M.D., et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 2010, 375:1920-1937.
4. Behr M.A., Warren S.A., Salamon H., Hopewell P.C., Ponce de Leon A., Daley C.L., et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 1999, 353:444-449.
5. Steingart K.R., Ramsay A., Pai M. Optimizing sputum smear microscopy for the diagnosis of pulmonary tuberculosis. Expert Rev Anti Infect Ther 2007, 5:327-331.
6. Pai M., Kalantri S., Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance. Expert Rev Mol Diagn 2006, 6:423-432.
7. World Health Organization Global tuberculosis control. A short update to the 2009 report 2009, WHO, Geneva, Switzerland.
8. World Health Organization New diagnostic working group of the stop TB partnership. Pathways to better diagnostics for tuberculosis - a blueprint for the development of TB diagnostics 2009, WHO, Geneva, Switzerland.
9. Cheng V.C., Yew W.W., Yuen K.Y. Molecular diagnostics in tuberculosis. Eur J Clin Microbiol Infect Dis 2005, 24:711-720.
10. Honore-Bouakline S., Vincensini J.P., Giacuzzo V., Lagrange P.H., Herrmann J.L. Rapid diagnosis of extrapulmonary tuberculosis by PCR: impact of sample preparation and DNA extraction. J Clin Microbiol 2003, 41:2323-2329.
11. Chakravorty S., Sen M.K., Tyagi J.S. Diagnosis of extrapulmonary tuberculosis by smear, culture, and PCR using universal sample processing technology. J Clin Microbiol 2005, 43:4357-4362.
12. Van Rie A., Page-Shipp L., Scott L., Sanne I., Stevens W. Xpert((R)) MTB/RIF for point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope?. Expert Rev Mol Diagn 2010, 10:937-946.
13. Blakemore R., Story E., Helb D., Kop J., Banada P., Owens M.R., et al. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol 2010, 48:2495-2501.
14. Helb D., Jones M., Story E., Boehme C., Wallace E., Ho K., et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol 2010, 48:229-237.
15. Banada P.P., Sivasubramani S.K., Blakemore R., Boehme C., Perkins M.D., Fennelly K., et al. Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings. J Clin Microbiol 2010, 48:3551-3557.
16. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. J Am Med Assoc 2000, 283:2008-2012.
17. Whiting P., Rutjes A.W., Dinnes J., Reitsma J., Bossuyt P.M., Kleijnen J. Development and validation of methods for assessing the quality of diagnostic accuracy studies. Health Technol Assess 2004, 8:1-234. iii.
18. Gatsonis C., Paliwal P. Meta-analysis of diagnostic and screening test accuracy evaluations: methodologic primer. AJR Am J Roentgenol 2006, 187:271-281.
19. Antonelli P., Chiumello D., Cesana B.M. Statistical methods for evidence-based medicine: the diagnostic test. Part II. Minerva Anestesiol 2008, 74:481-488.
20. Cesana B.M., Antonelli P., Chiumello D. Statistical methods for evidence-based medicine: the diagnostic test. Part I. Minerva Anestesiol 2008, 74:431-437.
21. Zamora J., Abraira V., Muriel A., Khan K., Coomarasamy A. Meta-Disc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006, 6:31.
22. Nicol M.P., Workman L., Isaacs W., Munro J., Black F., Eley B., et al. Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. Lancet Infect Dis 2011.
23. Teo J., Jureen R., Chiang D., Chan D., Lin R. Comparison of two nucleic acid amplification assays, the Xpert MTB/RIF assay and the amplified mycobacterium tuberculosis direct assay, for detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. J Clin Microbiol 2011, 49:3659-3662.
24. Scott L.E., McCarthy K., Gous N., Nduna M., Van Rie A., Sanne I., et al. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study. PLoS Med 2011, 8(7):e1001061.
25. Bodmer T., Strohle A. Diagnosing pulmonary tuberculosis in a low prevalence setting - the Xpert MTB/RIF test. Clin Microbiol Infect 2010, 16:S609-S610.
26. Marlowe E.M., Novak-Weekley S.M., Cumpio J., Sharp S.E., Momeny M.A., Babst A., et al. Evaluation of the cepheid Xpert MTB/RIF assay for direct detection of mycobacterium tuberculosis complex in respiratory specimens. J Clin Microbiol 2011, 49:1621-1623.
27. Theron G., Peter J., van Zyl-Smit R., Mishra H., Streicher E., Murray S., et al. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med 2011, 184:132-140.
28. Boehme C.C., Nicol M.P., Nabeta P., Michael J.S., Gotuzzo E., Tahirli R., et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011, 377:1495-1505.
29. Miller M.B., Popowitch E.B., Backlund M.G., Ager E.P.C. Performance of Xpert MTB/RIF RUO assay and IS6110 real-time PCR for mycobacterium tuberculosis detection in clinical samples. J Clin Microbiol 2011, 49:3458-3462.
30. Rachow A., Zumla A., Heinrich N., Rojas-Ponce G., Mtafya B., Reither K., et al. Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by cepheid Xpert MTB/RIF assay - a clinical validation study. PLoS One 2011, 6.
31. Malbruny B., Le Marrec G., Courageux K., Leclercq R., Cattoir V. Rapid and efficient detection of Mycobacterium tuberculosis in respiratory and non-respiratory samples. Int J Tuberc Lung Dis 2011, 15:553-555.
32. Moure R., Munoz L., Torres M., Santin M., Martin R., Alcaide F. Rapid detection of Mycobacterium tuberculosis complex and rifampin resistance in smear-negative clinical samples by use of an integrated real-time PCR method. J Clin Microbiol 2011, 49:1137-1139.
33. Boehme C.C., Nabeta P., Hillemann D., Nicol M.P., Shenai S., Krapp F., et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010, 363:1005-1015.
34. Lawn S.D., Brooks S.V., Kranzer K., Nicol M.P., Whitelaw A., Vogt M., et al. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. PLoS Med 2011, 8.
35. Bowles E.C., Freyee B., van Ingen J., Mulder B., Boeree M.J., van Soolingen D. Xpert MTB/RIF(R), a novel automated polymerase chain reaction-based tool for the diagnosis of tuberculosis. Int J Tuberc Lung Dis 2011, 15:988-989.
36. Causse M., Ruiz P., Juan Bautista G.A., Casal M. Comparison of two molecular methods for the rapid diagnosis of extrapulmonary tuberculosis. J Clin Microbiol 2011.
37. Friedrich S.O., von Groote-Bidlingmaier F., Diacon A.H. Xpert MTB/RIF assay for diagnosis of pleural tuberculosis. J Clin Microbiol 2011, 49:4341-4342.
38. Vadwai V., Boehme C., Nabeta P., Shetty A., Alland D., Rodrigues C. Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis?. J Clin Microbiol 2011, 49:2540-2545.
39. Society A.T. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000, 161:1376-1395.
40. Traore H., Fissette K., Bastian I., Devleeschouwer M., Portaels F. Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance. Int J Tuberc Lung Dis 2000, 4:481-484.
41. C.D.C Reported tuberculosis in United States, 2005 2006, U.S. Department of Health and Human Services, CDC, Atlanta GA.
42. E.C.D.C. WHO Regional office of Europe. Tuberculosis surveillance in Europe 2009 2011, ECDC, Stockholm.
43. Hillemann D., Rusch-Gerdes S., Boehme C., Richter E. Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system. J Clin Microbiol 2011, 49:1202-1205.